Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Xue-Bin Zou"'
Autor:
Run-Cong Nie, Xue-Bin Zou, Shu-Qiang Yuan, Ying-Bo Chen, Shi Chen, Yong-Ming Chen, Guo-Ming Chen, Xiao-Jiang Chen, Tian-Qi Luo, Shu-Man Li, Jin-Ling Duan, Yun Wang, Yuan-Fang Li
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background We aimed to assess whether disease-free survival (DFS) could serve as a reliable surrogate endpoint for overall survival (OS) in adjuvant trials of pancreatic cancer. Methods We systematically reviewed adjuvant randomized trials f
Externí odkaz:
https://doaj.org/article/6d503751c8fe4b619183d4e2c6ea7ff3
Autor:
Run-Cong Nie, Shu-Qiang Yuan, Yun Wang, Xue-Bin Zou, Shi Chen, Shu-Man Li, Jin-Ling Duan, Jie Zhou, Guo-Ming Chen, Tian-Qi Luo, Zhi-Wei Zhou, Yuan-Fang Li
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: We assessed the surrogacy of objective response rate (ORR), disease control rate (DCR) and progression-free survival (PFS) for overall survival (OS) in anti-PD-1/PD-L1 trials of metastatic melanoma through a meta-analysis of randomized co
Externí odkaz:
https://doaj.org/article/20bdf2fd6f5e4a9ab17f29d320513726
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0160758 (2016)
PURPOSE:The value of adding induction chemotherapy to chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma (LA-NPC) remains controversial, yet high-risk patients with LA-NPC have poor outcomes after chemoradiotherapy. We aimed to ass
Externí odkaz:
https://doaj.org/article/1dd5d0a1da7b4f3ea622f252f979f0fc
Autor:
Yi-xin Hu, Cui-ju Yan, Miao Yun, Wei Zheng, Xue-bin Zou, Ya-fang Zhang, Ru-shuang Mao, Ling-ling Li, Jian-hua Zhou
Publikováno v:
The British Journal of Radiology.
Objective: To evaluate correlation between contrast-enhanced ultrasonography Liver Imaging Reporting and Data System (CEUS LI-RADS; v. 2017) categories (LR 3–5 vs LR-M) and outcomes in patients with early-stage hepatocellular carcinoma (HCC) after
Autor:
Jing Han, Xue Bin Zou, Jianwei Wang, Wei Zheng, Wei Liu, An Hua Li, Feng Han, Qing Guang Lin, Yu Zhen Mo, Zhi Xing Guo
Publikováno v:
Aging (Albany NY)
Background: Autophagy is a self-digesting process that can satisfy the metabolic needs of cells, and is closely related to development of cancer. However, the effect of autophagy-related genes (ARGs) on the prognosis of breast cancer remains unclear.
Autor:
Xiaobo Huang, Xue-Bin Zou, Zhen He, Xiao-Wen Lan, Yuting Tan, Jiang-Hua Huang, Xiao Lin, Ge Wen
Publikováno v:
Cancer Management and Research
Xiao-Wen Lan,1,2,* Ge Wen,3,* Zhen He,4 Jiang-Hua Huang,1,2Xue-Bin Zou,5 Xiao Lin,1,6Yu-Ting Tan,1,6Xiao-Bo Huang1–2,61Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memo
Autor:
Guo-Ming Chen, Shi Chen, Zhiwei Zhou, Tian-Qi Luo, Yun Wang, Run-Cong Nie, Xue-Bin Zou, Yuan Fang Li, Jie Zhou, Shu-Man Li, Shu-Qiang Yuan, Jin-Ling Duan
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology
Background: We assessed the surrogacy of objective response rate (ORR), disease control rate (DCR) and progression-free survival (PFS) for overall survival (OS) in anti-PD-1/PD-L1 trials of metastatic melanoma through a meta-analysis of randomized co
Autor:
Run-Cong Nie, Xue-Bin Zou, Shu-Qiang Yuan, Ying-Bo Chen, Shi Chen, Yong-Ming Chen, Guo-Ming Chen, Xiao-Jiang Chen, Tian-Qi Luo, Shu-Man Li, Jin-Ling Duan, Yun Wang, Yuan-Fang Li
Background: We aimed to assess whether disease-free survival (DFS) could serve as a reliable surrogate endpoint for overall survival (OS) in adjuvant trials of pancreatic cancer. Methods: We systematically reviewed adjuvant randomized trials for non-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b1419624d6fa09c04aea650f2d54eb8
https://doi.org/10.21203/rs.2.13766/v4
https://doi.org/10.21203/rs.2.13766/v4
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 8, p e0160758 (2016)
PLoS ONE, Vol 11, Iss 8, p e0160758 (2016)
Purpose The value of adding induction chemotherapy to chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma (LA-NPC) remains controversial, yet high-risk patients with LA-NPC have poor outcomes after chemoradiotherapy. We aimed to ass
Publikováno v:
OncoTargets & Therapy; Aug2017, Vol. 10, p3853-3860, 8p